4//SEC Filing
Apeiron Investment Group Ltd. 4
Accession 0000950170-24-045120
CIK 0001840904other
Filed
Apr 16, 8:00 PM ET
Accepted
Apr 17, 4:15 PM ET
Size
10.0 KB
Accession
0000950170-24-045120
Insider Transaction Report
Form 4
Angermayer Christian
Director10% Owner
Transactions
- Other
Convertible Notes
2024-04-15−147,950→ 0 total(indirect: By Apeiron Investment Group Ltd.)→ Common Shares (2,367,200 underlying) - Other
Convertible Notes
2024-04-15+147,950→ 147,950 total(indirect: By Apeiron Investment Group Ltd.)From: 2024-04-15Exp: 2025-09-30→ Common Shares (2,367,200 underlying)
Apeiron Investment Group Ltd.
10% Owner
Transactions
- Other
Convertible Notes
2024-04-15−147,950→ 0 total(indirect: By Apeiron Investment Group Ltd.)→ Common Shares (2,367,200 underlying) - Other
Convertible Notes
2024-04-15+147,950→ 147,950 total(indirect: By Apeiron Investment Group Ltd.)From: 2024-04-15Exp: 2025-09-30→ Common Shares (2,367,200 underlying)
Footnotes (4)
- [F1]The conversion price for the Convertible Notes is EUR 17.00 per note.
- [F2]Represents an exchange of Convertible Notes issued by ATAI Life Sciences AG for Convertible Notes issued by the Issuer with substantially similar terms and economics.
- [F3]Each Convertible Note bears a notional principal amount of EUR 1.00.
- [F4]The reportable securities are held by Apeiron Investment Group Ltd. ("Apeiron"). Christian Angermayer, as the majority shareholder of Apeiron, may be deemed to beneficially own the securities.
Documents
Issuer
ATAI Life Sciences N.V.
CIK 0001840904
Entity typeother
IncorporatedMalta
Related Parties
1- filerCIK 0001845711
Filing Metadata
- Form type
- 4
- Filed
- Apr 16, 8:00 PM ET
- Accepted
- Apr 17, 4:15 PM ET
- Size
- 10.0 KB